(Q48961365)

17 February 2018

title

Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. (English)

1 reference

17 February 2018

0 references

1 reference

Mark C Smith

3

0 references

John M Buatti

object named as

John Buatti

1

0 references

Minesh Mehta

object named as

Minesh Mehta

6

0 references

author name string

Timothy C Ryken

2

1 reference

17 February 2018

Penny Sneed

4

1 reference

17 February 2018

John H Suh

5

1 reference

17 February 2018

Jeffrey J Olson

7

1 reference

17 February 2018

publication date

20 August 2008

1 reference

17 February 2018

Journal of Neuro-Oncology

published in

1 reference

17 February 2018

volume

89

1 reference

17 February 2018

page(s)

313-337

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-008-9617-2

exact match

0 references

cites work

Treatment of malignant glioma. A controlled study of chemotherapy and irradiation

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Postoperative Irradiation of Glioblastomas: Results in a Randomized Series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Patterns of second recurrence of malignant astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Misonidazole combined with hyperfractionation in the management of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Short course radiotherapy is an appropriate option for most malignant glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Stereotactic radiosurgery for glioblastoma: a final report of 31 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Linac radiosurgery for high-grade gliomas: the University of Florida experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Gamma knife for glioma: selection factors and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9617-2

Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

21 January 2018

1 reference

12 December 2020

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

1 reference

12 December 2020

[Radiotherapy of malignant glioma--prospective randomized clinical study of whole brain vs local irradiation]

1 reference

12 December 2020

Results of interstitial brachytherapy for malignant brain tumors.

1 reference

12 December 2020

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

12 December 2020

Fractionation study in the treatment of glioblastoma multiforme

1 reference

12 December 2020

Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage

1 reference

12 December 2020

Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost

1 reference

12 December 2020

Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial.

1 reference

12 December 2020

The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine

1 reference

12 December 2020

Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.

1 reference

12 December 2020

Superfractionated radiotherapy in grade III, IV intracranial gliomas

1 reference

12 December 2020

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

1 reference

12 December 2020

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

1 reference

12 December 2020

European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey

1 reference

12 December 2020

Hypofractionation in glioblastoma multiforme.

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme

1 reference

12 December 2020

Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?

1 reference

12 December 2020

A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma.

1 reference

12 December 2020

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

1 reference

12 December 2020

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes

1 reference

12 December 2020

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

12 December 2020

Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report

1 reference

12 December 2020

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

12 December 2020

Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas.

1 reference

12 December 2020

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

1 reference

12 December 2020

A prospective study of short course radiotherapy in elderly patients with malignant glioma.

1 reference

12 December 2020

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.

1 reference

12 December 2020

Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma.

1 reference

12 December 2020

Superfractionation radiation therapy in the treatment of malignant astrocytoma.

1 reference

12 December 2020

Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis

1 reference

12 December 2020

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas

1 reference

12 December 2020

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

1 reference

12 December 2020

Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02

1 reference

12 December 2020

Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme.

1 reference

12 December 2020

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

12 December 2020

The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial

1 reference

12 December 2020

10.1007/S11060-008-9617-2

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

18712283

1 reference

17 February 2018